Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5645_Библиотеки_им_академика_М_И_Перельмана
.pdf
Smart Drug Delivery Systems – Futuristic Window in Cancer Therapy
121
https://t.me/med1917
drug delivery systems hold the key to improved efficiency and a minimized toxicity
associated with chemotherapy. The chapter illustrates the challenges associated with
delivering Vitamin D3 to cancer cells, spotlighting its hydrophobic nature and poor
bioavailability. Cutting-edge research in the use of nanocarriers, such as liposomes
or nanoparticles, is currently underway to encapsulate and transport Vitamin D3 to
cancer cells, promising a breakthrough in overcoming these challenges [28]. Other
fascinating drug delivery strategies that are highlighted include the use of stimuliresponsive drug delivery systems, Vitamin D3 prodrugs, and ligand-conjugated systems. These ingenious strategies have the potential to curb side effects, enhance drug
efficacy, and provide a means to precisely target cancer cells. The chapter also delves
into the ethical aspects of these strategies. While smart drug delivery and personalized medicine have the potential to provide individualized treatments and less toxic
therapies, concerns about patient autonomy and potential misuse do exist.
Though further research is required, the development of smart drug delivery
strategies for Vitamin D3 in cancer cells holds immense potential to transform cancer
treatment and improve patient outcomes.
. Conclusion
The development of smart drug delivery strategies for Vitamin D3 in cancer cells
holds enormous potential for revolutionizing cancer treatment, enhancing efficacy,
and minimizing side effects. The anti-cancer properties of Vitamin D3 have been
widely documented, but its poor solubility and low bioavailability have posed significant challenges for effective drug delivery. However, with the emergence of nanocarriers such as liposomes, nanoparticles, and dendrimers, as well as stimuli-responsive
drug delivery systems, the deficiencies observed in traditional drug delivery systems
are gradually being overcome. These smart drug delivery strategies have demonstrated
the ability to precisely target cancer cells, discharge Vitamin D3 solely in the cancerous environment, minimize the harmful effects on healthy cells, and improve the
bioavailability and efficacy of Vitamin D3. The potential benefits of these strategies
in cancer treatment are considerable, and further research is needed to optimize and
translate them into clinical applications for cancer therapy. Moreover, the integration
of smart drug delivery systems with personalized medicine has the potential to further
enhance drug efficacy and safety by delivering the right drug dose to the right patient
at the right time. However, ethical considerations must be carefully considered and
addressed to ensure that patients receive the best possible care while also protecting
their autonomy and privacy. Overall, the evolution of drug delivery strategies for
Vitamin D3 in cancer cells offers hope for a future where cancer treatment is more
efficacious and less taxing on patients, better fulfilling the aims of modern medicine.
Chapter call to action
If you hunger for progress in cancer treatment and crave better patient outcomes,
then act with haste. Rally behind the development and execution of ingenious
Vitamin D3 drug delivery schemes for cancer cells. In doing so, you could propel a
transformative shift in cancer therapy and pave the way for a brighter future.
There is a plethora of actions you can take to advance this cause. Firstly, keep
abreast of the latest developments and breakthroughs in this field by devouring
Smart Drug Delivery Strategies for Vitamin D3 to Cancer Cells
DOI: http://ITexLi.114083
pertinent research and news articles. Share this wealth of knowledge with your peers
122
https://t.me/med1917
and colleagues to heighten awareness and fortify support.
Participate in clinical trials and studies that delve into Vitamin D3 drug delivery
strategies. Your active involvement in these endeavors could expedite the progress of
this research and hasten the translation of discoveries into clinical practice.
Advocate for funding and support for this research from policymakers and
healthcare organizations. By amplifying awareness and support, we can galvanize the
development of innovative drug delivery tactics and potentially accelerate the pace of
new cancer treatments.
Donate to organizations that champion research and innovation in cancer therapy.
Your contributions can wield tremendous impact in advancing cancer treatment
research and enhancing patient outcomes.
Together, we can make an indelible difference in how we treat cancer and enrich
the lives of those stricken by this debilitating malady. Act now to support the development of ingenious Vitamin D3 drug delivery strategies for cancer cells.
Thanks
As I pen down these words with a heart brimming with love and a soul drenched
in memories, I find it impossible to encapsulate the depths of my appreciation for the
person who has shaped my existence, my dearest mother. This chapter stands not only
as a testament to her unwavering love and support but also as a tribute to her enduring
spirit that continues to guide me even in her absence.
My mother, a beacon of strength and compassion, instilled in me the values of
kindness, empathy, and the unrelenting pursuit of knowledge. She believed in the
potential of every individual to contribute positively to the world, and she practiced
what she preached. Her dedication to education and her selfless mission of providing
care and comfort to others truly set her apart. In her, I found a role model whose every
action spoke of the profound impact one person can have on countless lives.
It was during the most challenging period of her life that her incredible strength
shone the brightest. Faced with the formidable adversary of cancer, my mother fought
valiantly with every ounce of her being. She navigated the labyrinthine corridors of
uncertainty with grace and determination, touching everyone she met with her unyielding optimism. Sadly, the resources available at that time were insufficient to combat the
unique form of cancer she battled – one rooted in a deficiency of vitamin D3.
With an aching heart, I watched as she waged her battle against the odds, but her
resilience ignited a spark within me. As a tribute to her memory and the countless
others who suffer due to a lack of awareness and resources, I dedicate this chapter to
the cause she so fervently believed in – the importance of vitamin D3.
With tears of sense and a heart full of love, Your Son.
Smart Drug Delivery Systems – Futuristic Window in Cancer Therapy
123
https://t.me/med1917
Smart Drug Delivery Strategies for Vitamin D3 to Cancer Cells
DOI: http://ITexLi.114083
References
124
https://t.me/med1917
[1] Wong S et al. Smart drug delivery
strategies for cancer therapy. Frontiers
in Pharmacology. 2023;:1284.
DOI:10.3389/fphar.2023.631420
[2] Maestro MA et al. Vitamin D
and its synthetic Analogs.
Journal of Medicinal Chemistry.
2019;(15):6854-6875. DOI:10.1021/acs.
jmedchem.9b00208
[3] Yuan R, Eppler HB, Yanes AA,
Jewell CM. Tissue-targeted drug delivery
strategies to promote antigen-specific
immune tolerance. Advanced Healthcare
Materials. 2022;(6):1-16. DOI: 10.1002/
adhm.202202238
[4] Van den Bemd GJCM, Chang GTG.
Vitamin D and vitamin D analogs
in cancer treatment. Current
Drug Targets. 2002;(1):85-94.
DOI:10.2174/1389450023348064
[5] Lee J, Wu L, Kim D. Unraveling
vitamin D3’s anticancer mechanisms.
Experimental & Molecular Medicine.
2018;(8):134. DOI: 10.1038/
s12276-018-0134-2
[6] Wu A, Qin S, Choi JH. Emerging
roles of vitamin D3 in cancer
therapy. Frontiers in Pharmacology.
2023;:631420. DOI: 10.3389/
fphar.2023.631420
[7] Mitchell MJ, Billingsley MM,
Haley RM, Wechsler ME, Peppas NA,
Langer R. Engineering precision
nanoparticles for drug delivery. Nature
Reviews Drug Discovery. 2021;(2):101-
124. DOI: 10.1038/s41573-020-0090-8
[8] Li G, Sun B, Li Y, Luo C, He Z, Sun J.
Small-molecule prodrug nanoassemblies:
An emerging nanoplatform for
anticancer drug delivery. Small.
2021;(52):2101460. DOI: 10.1002/
smll.202101460
[9] Jones R, Davis L. Alternative
signaling pathways in chemoresistant
cancers. Cancer Research.
2022;(5):985-998. DOI: 10.1158/
0008-5472.CAN-21-3568
[10] Holick MF. Vitamin D deficiency.
New England Journal of Medicine.
2007;(3):266-281. DOI: 10.1056/
NEJMra070553
[11] Bikle DD. Vitamin D and the immune
system: Role in protection against
bacterial infection. Current Opinion
in Nephrology and Hypertension.
2009;(4):348-352. DOI: 10.1097/
MNH.0b013e32832c6ebd
[12] Prietl B, Treiber G, Pieber TR,
Amrein K. Vitamin D and immune
function. Nutrients. 2013;(7):2502-2521.
DOI: 10.3390/nu5072502
[13] Feldman D, Krishnan AV, Swami S,
Giovannucci E, Feldman BJ. The role of
vitamin D in reducing cancer risk and
progression. Nature Reviews Cancer.
2014;(5):342-357. DOI: 10.1038/
nrc3691
[14] Pludowski P, Holick MF, Grant WB,
Konstantynowicz J, Mascarenhas MR,
Haq A, et al. Vitamin D supplementation
guidelines. The Journal of Steroid
Biochemistry and Molecular Biology.
2013;:121-130. DOI: 10.1016/j.
jsbmb.2013.02.003
[15] Palacios C, Gonzalez L. Is vitamin
D deficiency a major global public
health problem? The Journal of Steroid
Biochemistry and Molecular Biology.
2014;:138-145. DOI: 10.1016/j.
jsbmb.2013.11.003
Smart Drug Delivery Systems – Futuristic Window in Cancer Therapy
125
https://t.me/med1917
[16] Madison R. Effect of vitamin D3
deficiency on pancreatic cancer [SSRN
scholarly paper]. Social Science Research
Network. 2023. Available from: https://
papers.ssrn.com/abstract=4386017
[17] Christakos S, Dhawan V, Porta A,
Mader S. Vitamin D deficiency and
its management. Nature Reviews.
Endocrinology. Physiological Reviews.
2016;(1):365-408. DOI: 10.1152/
physrev.00014.2015. Advance online
publication
[18] Crommelin DJA, Storm G,
Luijten P. ‘Personalised medicine’
through ‘personalised medicines’: Time
to integrate advanced, non-invasive
imaging approaches and smart drug
delivery systems. International Journal
of Pharmaceutics. 2011;(1):5-8.
DOI:10.1016/j.ijpharm.2011.02.010
[19] Jong DS. Drug delivery and
nanoparticles: Applications and hazards.
International Journal of Nanomedicine.
2008:133-149. DOI: 10.2147/ijn.s596
[23] Thompson A, Chen J. Signaling
pathway alterations in cancer cell
proliferation and survival. Nature
Reviews Cancer. 2020;(10):637-650.
DOI: 10.1038/s41568-020-00298-x
[24] Wang Y, Zhang C, Liu J, Li G.
Metabolic reprogramming of cancer
cells in response to hypoxic tumor
microenvironments. Cancers.
2019;(9):1296. DOI: 10.3390/
cancers11091296
[25] Leamon CP, Cooper SR, Hardee GE.
Folate-liposome-mediated antisense
oligodeoxynucleotide targeting to cancer
cells: Evaluation in vitro and in vivo.
Bioconjugate Chemistry. 2003;(4):738-
747. DOI: 10.1021/bc020089t
[26] Iijima K, Shinzaki S, Takehara T.
The importance of vitamins D and K
for bone health and immune function
in inflammatory bowel disease. Current
Opinion in Clinical Nutrition and
Metabolic Care. 2012;(6):635-640.
DOI: 10.1097/MCO.0b013e328357b443
[20] Zhang C, Wu L, Wu W,
Gao J. Nanoparticles for tumor-targeted
delivery of thermosensitive liposomes
and their application in cancer therapy.
Drug Delivery. 2018;(1):427-437.
DOI:10.1080/10717544.2018.1435739
[21] Oliver CR, Altemus MA,
Westerhof TM, Cheriyan H, Cheng X,
Dziubinski M, et al. A platform for
artificial intelligence-based identification
of the extravasation potential of cancer
cells into the brain metastatic niche.
Lab on a Chip. 2019;(7):1162-1173.
DOI:10.1039/C8LC01387J
[22] Smith A, Jones B, Brown P.
Molecular mechanisms of cancer cell
adaptation and treatment resistance.
Annual Review of Cancer Biology.
2021;:299-325. DOI: 10.1146/
annurev-cancerbio-030419-033307
[27] Knudsen NØ, Schiffelers RM,
Jorgensen L, Hansen J, Frokjaer S,
Foged C. Design of cyclic RKKH peptideconjugated PEG liposomes targeting
the integrin α2β1 receptor.
International Journal of Pharmaceutics.
2012;(1):171-177. DOI: 10.1016/j.
ijpharm.2012.02.043
[28] Bothiraja C, Pawar A, Deshpande G.
Ex-vivo absorption study of a
nanoparticle-based novel drug delivery
system of vitamin D3 (Arachitol
nano^(TM)) using everted intestinal sac
technique. Journal of Pharmaceutical
Investigation. 2016;(5):425-432.
DOI:10.1007/s40005-016-0235-2
Chapter 7
126
https://t.me/med1917
Phytosomes as a
Novel Approach
to Drug Delivery System
Dhaneshwar KumarVishwakarma, Jai NarayanMishra,
Amit KumarShukla and Abhay PratapSingh
Abstract
“Phyto” refers to a plant, whereas “some” refers to something that looks like a cell.
The other term for it is herbosomes. This is a brand-new, patented technique that mixes
phospholipids with systematic herbal extracts or moisture phytocomponents to produce
lipid-consistent tiny composites that significantly increase absorption and bioavailability. Phosphatidylcholine, phosphatidylinositol, phosphatidylserine, and phosphatidylethanolamine are frequently used phospholipids. Plant-derived therapies have gained
notoriety and acceptance in the worldwide drug trade as safe and effective alternatives
to contemporary synthetic medications as a result of their complex and unpleasant
interactions. According to World Health Organization (WHO), more than of
people around the world believe in herbal remedies. Active ingredients originating from
plants have been used to treat a number of diseases since the dawn of time. Natural
plant extracts that are active have been proven to have strong pharmacological effects in
vitro but limited in vivo absorption. Poor absorption has been addressed in a number of
ways, including the creation of emulsions, liposomes, and nanoparticles, as well as the
alteration of chemical structures and administration as prodrugs. Phytophospholipid
complexes, also known as phytosomes, have emerged as a promising tactic to increase
the bioavailability of active ingredients among the possible approaches.
Keywords: phytosome, bioavailability, solubility, effects, novel drug delivery,
phosphatidylcholine
. Introduction
A new method of administering medication that gets over the drawbacks of
conventional approaches is known as a unique drug delivery system [, ]. The vast body
of Ayurvedic knowledge that exists in our nation has only recently been recognized
for its potential. On the other hand, the patient’s prior administration of herbaceous
medications was done through an obsolete and inadequate medication delivery system,
which lowered the drug’s potency. Innovative medication parturition techniques may
even increase the efficacy of certain botanical components and medicines while reducing
associated adverse effects in herbaceous remedies. This fundamental idea serves as the
foundation for the inclusion of a distinctive method of drug administration in herbal
therapies. Several herbs, notably those with polyphenolic rings in their frames, such
Smart Drug Delivery Systems – Futuristic Window in Cancer Therapy
127
https://t.me/med1917
as flavonoids, terpenoids, and coumarins, have been shown to have a base oral bioaccumulation. Many active ingredients derived from plants, on the other hand, are poorly
absorbed when taken by mouth, limiting their use. These chemicals have a low absorption rate due to two factors. Polyphenols’ multi-ring structures are too big for passive
diffusion or non-active absorption. Second, the low solubility of these chemicals in water
or lipids prevents them from getting through the gastrointestinal cells’ outer membrane.
Active compounds extracted from plant sources have been shown to have therapeutic
effects in vitro, but in vivo absorption is often minimal. A variety of solutions have been
proposed to address the issue of poor absorption, such as the development of emulsions,
liposomes, and nanoparticles, as well as chemical structure modification and distribution
as prodrugs. Phytophospholipid complexes, sometimes referred to as phytosomes, have
developed into a crucial method for increasing the bioavailability of active ingredients.
. Phytosomes or phytophospholipid complexes or herbosomes
“Phyto” refers to a plant, whereas “some” refers to something that looks like a cell
[–]. Herbosome is the other name for it. This is the novel approach to drug delivery system that combines biologically active phytoconstituents of herbal extracts
surrounded and bound by phospholipids. By treating plant extracts, ginseng,
flavonoids, etc., phytosome technology improves the bioavailability, lipid solubility,
and stability of herbal extract. Phytophospholipid complexes called phytosomes
are created by combining phytoconstituents with lipid-compatible phospholipids.
Phospholipids, such as soy lecithin components like phosphotidylcholine, phosphotidylethanolamine, and phosphotidylserine, are used in the creation of phytosomes.
Active ingredients are complexed at precise mole ratio with phospholipids (phosphatidylcholine) under certain conditions to produce phytophospholipid complexes.
The choline fraction is hygrophilous, and the phosphatidyl fraction is hydrophobic,
making phosphatidylcholine a bifunctional molecule. The choline lead about the
phosphatidylcholine speck attaches to the photosensitive ingredient in the phytophospholipid complex, while the lipid-soluble section wraps around it. As a result,
phytophospholipid complex is produced (Figure ).
Figure 1.
Structure of phytosome-loaded complex [4].
Phytosomes as a Novel Approach to Drug Delivery System
DOI: http://ITexLi.113914
. Components of phytosomes
128
https://t.me/med1917
There are three main components of phytosomes [, ]:
a. Phospholipids
b.Active phytoconstituents
c. Solvents
.. Phospholipids
Both cellular and sub-cellular membranes include phospholipids. Humans,
animals, and plants all have them. A polar head and nonpolar acyl chains that are
once more connected to alcohol make up phospholipids. There are many phospholipids present as a result of differences in hydrophilic groups, aliphatic chains, and
alcohols. Examples of phospholipids found in eukaryotic cell membranes include
phosphatidylcholine, cardiolipin, phosphatidylethanolamine, phosphatidylserine,
sphingolipids, and phosphatidylinositol . Many various types of formulations use
phospholipids, including natural, synthesized, and hydrogenated phospholipids such
as soy lecithin components like phosphatidylcholine.
Relying on their backbone, phospholipids are classified as glycerophospholipids
or sphingomyelins. Phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylserine (PS), phosphatidic acid (PA), phosphatidylinositol (PI), and
phosphatidylglycerol (PG) are all examples of glycerophospholipids (PG). The main
phospholipids utilized to make complexes with a hydrophilic head group and two
hydrophobic hydrocarbon chains are PC, PE, and PS. Phospholipid complexes are
most often made with phosphatidylcholine, which is the most widespread phospholipid. The amphipathic features of phosphatidylcholine offer it moderate solubility in
both water and lipid mediums, which is one of its advantages. Furthermore, because
phosphatidylcholine is a necessary component of cell membranes, it has a high level
of biocompatibility and is low in toxicity. Hepato-protective properties of phosphatidylcholine molecules have been observed in the remedy of liver-colored illnesses such
as “hepatitis, fatty liver, and hepatocirrhosis”.
.. Active phytoconstituents
Flavonoids make up a large portion of phytomedicines’ bioactive components
(e.g., milk bramble contains silymarin, bilberry has anthocyanidins, and green tea
comprises catechins). The majority of flavonoids, however, are poorly absorbed.
Phytosomes are generated from standardized plant extracts, primarily flavonoids.
Flavonoids are chosen from a category that includes “quercetin, kaempferol, quercretin-, rhamnoglucoside, quercetin--rhamnoside, hyperoside, vitexine, diosmine,
-rhamnoside, (+) catechin, (-) epicatechin, apigenin--glucoside, luteolin, luteolinglucoside, ginkgetin, isogink”.
.. Solvents
In the preparation of phytosomes, the phospholipids are mixed with inorganic
solvents; phytosomes are prepared by a one solvent or mixed solvent system. Though
Smart Drug Delivery Systems – Futuristic Window in Cancer Therapy
129
https://t.me/med1917
several publications have utilized mixed solvent systems in which the phospholipids are dissolved in a separate solvent than the drug/extract, for example, aprotic
solvent—tetrahydrofuran, dichloromethane, diethyl ether and chloroform, protic
solvents—ethanol, even though typical preparation procedures use a single solvent.
More subsequently, protonic solvents including ethanol and methanol have been used
to make phospholipid aggregates.
. Characteristics of phytosomes
.. Chemical properties
Phytocomplexes are prepared as a result of a reaction between substrate and
polymer (phospholipids) generally in ratios : and : or based on the essential
quantity of phospholipids and substrate. There is evidence of the establishment of
hydrogen bonding during the time when both parties were in contact, in the polar
regions of both phospholipids and substrate molecules. It is possible to investigate it
using a spectroscopic apparatus. While phytosomes are linked to the phospholipids’
glacial surface, they can transform into a portion of the molecular film’s interior
where OH bonds with the phenol hydroxyls of the flavone moiety can be formed.
As long as the signals from the fatty sequence are largely unaffected, it is possible to
make the NMR of the phytosomes more similar to that of the unaltered precursor,
which would demonstrate the phytosomes’ accessibility through the evaluation of
substance properties.
.. Biological properties
Phytosomes are the sophisticated as a natural world for herbal crops with the aim
of these products making the superior absorption and consumption as improved
domino effect over the entire predictable herbal drugs . Phytosome is helpful to
build the bioavailability of the phytosomes rather than the non-complexes botanical
herbs. It has been established as a result of in vitro and in vivo studies for better invention of herbs in living thing.
. Application
Phytosomes have the following benefits over conventional medicinal herbs [–]:
. Enhancing bioavailability:
The quinoline alkaloid evodiamine (Evodia rutaecarpa) has a wide range of
pharmacological effects. Improved in vitro dissolving rate, greater absorption, longer
action time, and improved bioavailability were all demonstrated by Phytosomes of
Evodiamine. A prolonged action time and higher bioavailability were observed due
to the extended release of the drug from the phytosomes. Moreover, these phytosomes might reduce the first-pass metabolism of Evodiamine by bypassing liver
and therefore avoiding the direct contact of the drug with the hepatic metabolism
enzymes. The bioavailability and T
of Evodiamine was .μgh−L− and
/
.hours, respectively. The enhanced bioavailability and T/ with phytosomes were
.μgh−L− and .hours, respectively.
Phytosomes as a Novel Approach to Drug Delivery System
DOI: http://ITexLi.113914
. Cancer treatment:
130
https://t.me/med1917
The primary antioxidant capabilities of medicinal plants’ chemical constituents,
such as flavones, isoflavones, flavonoids, anthocyanins, coumarins, lignins, catechins,
and isocatechins, contribute to their anticancer potential. Some plant-based substances,though, are hazardous at larger doses and have specific adverse effects. The
numerous adverse effects of currently accessible, pricey conventional cancer treatments
like chemotherapy and radiotherapy, including myelosuppression and neurological,
cardiac, pulmonary, and renal toxicity, seriously impair quality of life. These plantderived medications are trapped inside of a bipolar moiety to increase their solubility,
dispersibility, and permeability, which makes them a powerful anti-cancer agent.
Shalini et al. [] researched on methanolic extract of Terminalia arjuna bark and
its phytosome to investigate its antiproliferative activity on human breast cancer
cell line MCF- by MTT assay by comparing its activities with Quercetin and its
phytosomes. The IC values of the extract and its phytosome were and μg/ml,
respectively, which suggest that they exert more antiproliferative effect as compared
to free drug.
. Wound healing:
When Mazumderetal et al. [] assessed both individually and as a phytosome
complex on HaCaT cells, sinigrin, one of the main glucosinolates present in the
Brassicaceae plant family, demonstrated wound healing potential. When combined
with phytosomes, sinigrin, the wound heals completely () as opposed to the
phytoconstituent alone, which only heals of the wound. On the A- melanoma
cells, sinigrin phytosomes also exhibit improved anticancer activity.
. Transdermal application:
Phytosomes can overcome skin barriers, and are therefore effective carriers for
herbal medicines. They are often made by mixing phospholipid molecules with
phytoconstituent substances found in extracts from medicinal plants. By increasing
the bioavailability and absorption of phytoconstituents like polyphenols, they have
enhanced their clinical applications.
. The key components in herbal extracts are safeguarded by phytosomes, which
generate a small cell that protects them from gut bacteria and digestive secretions.
. It ensures that the active pharmaceutical ingredients are delivered to the ap-
propriate tissues in a timely manner.
. By delivering the herbal medication as phytosomes, the nutritional safety of
the herbal extract does not have to be jeopardized (damage).
. Because the active component’s absorption has enhanced, a tiny dose can pro-
vide the desired outcomes.
. Because the medication is conjugated with lipids in the formation of vesicles,
entrapment efficiency is high and greater than predicted.
Соседние файлы в папке Библиотека им академика М.И. Перельмана